|
|
.
See Category: Endocrine, nutritional and metabolic diseases
ICD-10 (CM) Code and Descriptor
|
E85.2 |
Heredofamilial amyloidosis, unspecified
|
E852 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 46.97%
|
18.37%
|
13.95%
|
6.33%
|
5.11%
|
2.60%
|
1.73%
|
1.47%
|
1.39%
|
0.78%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E85.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J0222
|
INJ., PATISIRAN, 0.1 MG |
388
|
64,196
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
242
|
242
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
186
|
388
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
151
|
153
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
133
|
135
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
121
|
1,015
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
89
|
137
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
85
|
85
|
|
J1200
|
DIPHENHYDRAMINE HCL INJECTIO |
81
|
81
|
|
80053
|
COMPREHEN METABOLIC PANEL |
76
|
76
|
|
83880
|
ASSAY OF NATRIURETIC PEPTIDE |
60
|
62
|
|
J8540
|
ORAL DEXAMETHASONE |
58
|
1,188
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
56
|
71
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
56
|
105
|
|
96367
|
TX/PROPH/DG ADDL SEQ IV INF |
51
|
56
|
|
83735
|
ASSAY OF MAGNESIUM |
39
|
39
|
|
84134
|
ASSAY OF PREALBUMIN |
36
|
36
|
|
84156
|
ASSAY OF PROTEIN URINE |
35
|
35
|
|
84484
|
ASSAY OF TROPONIN QUANT |
34
|
34
|
|
82570
|
ASSAY OF URINE CREATININE |
33
|
34
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E85.2 related to the following DRG Codes:
545-547
|
